191 related articles for article (PubMed ID: 23990470)
21. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
Tsurupa G; Yakovlev S; McKee P; Medved L
Biochemistry; 2010 Sep; 49(35):7643-51. PubMed ID: 20687529
[TBL] [Abstract][Full Text] [Related]
22. Pentasaccharide enhances the inactivation of factor Xa by antithrombin by promoting the assembly of a Michaelis-type intermediate complex. Demonstration by rapid kinetic, surface plasmon resonance, and competitive binding studies.
Rezaie AR
Biochemistry; 2006 Apr; 45(16):5324-9. PubMed ID: 16618121
[TBL] [Abstract][Full Text] [Related]
23. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
Futamura A; Beechem JM; Gettins PG
Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
[TBL] [Abstract][Full Text] [Related]
24. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
Hogg PJ; Jackson CM
Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
[TBL] [Abstract][Full Text] [Related]
25. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains.
Tsurupa G; Medved L
Biochemistry; 2001 Jan; 40(3):801-8. PubMed ID: 11170397
[TBL] [Abstract][Full Text] [Related]
27. Fine mapping of the sequences in domain 5 of high molecular weight kininogen (HK) interacting with heparin and zinc.
Pixley RA; Lin Y; Isordia-Salas I; Colman RW
J Thromb Haemost; 2003 Aug; 1(8):1791-8. PubMed ID: 12911595
[TBL] [Abstract][Full Text] [Related]
28. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation.
Hotchkiss KA; Chesterman CN; Hogg PJ
Blood; 1994 Jul; 84(2):498-503. PubMed ID: 8025278
[TBL] [Abstract][Full Text] [Related]
31. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
Peterson CB; Morgan WT; Blackburn MN
J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
[TBL] [Abstract][Full Text] [Related]
32. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
[TBL] [Abstract][Full Text] [Related]
33. Interactions between factor XIII and the alphaC region of fibrinogen.
Smith KA; Adamson PJ; Pease RJ; Brown JM; Balmforth AJ; Cordell PA; Ariëns RA; Philippou H; Grant PJ
Blood; 2011 Mar; 117(12):3460-8. PubMed ID: 21224475
[TBL] [Abstract][Full Text] [Related]
34. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
Nishioka J; Suzuki K
J Biol Chem; 1992 Nov; 267(31):22224-9. PubMed ID: 1331047
[TBL] [Abstract][Full Text] [Related]
35. Localization of a heparin binding site in the catalytic domain of factor XIa.
Badellino KO; Walsh PN
Biochemistry; 2001 Jun; 40(25):7569-80. PubMed ID: 11412111
[TBL] [Abstract][Full Text] [Related]
36. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
Preissner KT; Müller-Berghaus G
J Biol Chem; 1987 Sep; 262(25):12247-53. PubMed ID: 2442161
[TBL] [Abstract][Full Text] [Related]
37. Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin.
Panetti TS; Kudryk BJ; Mosher DF
J Biol Chem; 1999 Jan; 274(1):430-7. PubMed ID: 9867861
[TBL] [Abstract][Full Text] [Related]
38. Thrombin interaction with fibrin polymerization sites.
Hsieh K
Thromb Res; 1997 May; 86(4):301-16. PubMed ID: 9187018
[TBL] [Abstract][Full Text] [Related]
39. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
Björk I; Ylinenjärvi K; Olson ST; Bock PE
J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
[TBL] [Abstract][Full Text] [Related]
40. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
